Rheopheresis in treatment of idiopathic sensorineural sudden hearing loss

Abstract Backround Only few therapeutic options exist for patients with refractory sudden idiopathic sensorineural hearing loss (SISHL). Little is known about the efficacy of second-line therapies. Rheopheresis seems to be an effective therapeutic possibility. Methods Between 2012 and 2015, 106 pati...

Full description

Saved in:
Bibliographic Details
Main Authors: Milan Kostal, Jakub Drsata, Milan Bláha, Miriam Lánská, Viktor Chrobok
Format: Article
Language:English
Published: SAGE Publishing 2017-06-01
Series:Journal of Otolaryngology - Head and Neck Surgery
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40463-017-0228-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544119071703040
author Milan Kostal
Jakub Drsata
Milan Bláha
Miriam Lánská
Viktor Chrobok
author_facet Milan Kostal
Jakub Drsata
Milan Bláha
Miriam Lánská
Viktor Chrobok
author_sort Milan Kostal
collection DOAJ
description Abstract Backround Only few therapeutic options exist for patients with refractory sudden idiopathic sensorineural hearing loss (SISHL). Little is known about the efficacy of second-line therapies. Rheopheresis seems to be an effective therapeutic possibility. Methods Between 2012 and 2015, 106 patients with SISHL were enrolled in the study, of whom 52 were refractory to initial treatment. As salvage therapy, these patients were offered either 3 sessions of rheopheresis (33 pts) or intratympanic steroid treatment through MicroWick application (19 pts). Pure tone audiometry was performed at diagnosis, at the 1st month and the 1st year during the follow-up. Results Patients in the rheopheretic arm had higher hearing loss than in the MicroWick arm (81% vs. 52%, p = 0.04). In spite of this, there was a significant improvement for patients in the rheopheretic arm (27% of hearing loss reduction, p < 0.001) after the 1st month and this remained unchanged during the 1st year, while no improvement was seen in the MicroWick arm (0% of hearing loss reduction, p = 0.424). We found no predictive factor for steroid-failure in first-line therapy. Older age (p = 0.003), presence of vertigo (p = 0.006) and more profound initial hearing loss (p < 0.001) were identified as negative prognostic markers. Conclusion Rheopheresis can be used as a potentially effective and safe salvage therapy for patients with cortico-refractory SISHL.
format Article
id doaj-art-47c77209f15247eab5ba400f8d1ca884
institution Kabale University
issn 1916-0216
language English
publishDate 2017-06-01
publisher SAGE Publishing
record_format Article
series Journal of Otolaryngology - Head and Neck Surgery
spelling doaj-art-47c77209f15247eab5ba400f8d1ca8842025-02-03T10:54:10ZengSAGE PublishingJournal of Otolaryngology - Head and Neck Surgery1916-02162017-06-014611710.1186/s40463-017-0228-9Rheopheresis in treatment of idiopathic sensorineural sudden hearing lossMilan Kostal0Jakub Drsata1Milan Bláha2Miriam Lánská3Viktor Chrobok44th Department of Internal Medicine, University Hospital Hradec Kralove Charles University, Faculty of Medicine in Hradec KraloveDepartment of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove Charles University, Faculty of Medicine in Hradec Kralove4th Department of Internal Medicine, University Hospital Hradec Kralove Charles University, Faculty of Medicine in Hradec Kralove4th Department of Internal Medicine, University Hospital Hradec Kralove Charles University, Faculty of Medicine in Hradec KraloveDepartment of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove Charles University, Faculty of Medicine in Hradec KraloveAbstract Backround Only few therapeutic options exist for patients with refractory sudden idiopathic sensorineural hearing loss (SISHL). Little is known about the efficacy of second-line therapies. Rheopheresis seems to be an effective therapeutic possibility. Methods Between 2012 and 2015, 106 patients with SISHL were enrolled in the study, of whom 52 were refractory to initial treatment. As salvage therapy, these patients were offered either 3 sessions of rheopheresis (33 pts) or intratympanic steroid treatment through MicroWick application (19 pts). Pure tone audiometry was performed at diagnosis, at the 1st month and the 1st year during the follow-up. Results Patients in the rheopheretic arm had higher hearing loss than in the MicroWick arm (81% vs. 52%, p = 0.04). In spite of this, there was a significant improvement for patients in the rheopheretic arm (27% of hearing loss reduction, p < 0.001) after the 1st month and this remained unchanged during the 1st year, while no improvement was seen in the MicroWick arm (0% of hearing loss reduction, p = 0.424). We found no predictive factor for steroid-failure in first-line therapy. Older age (p = 0.003), presence of vertigo (p = 0.006) and more profound initial hearing loss (p < 0.001) were identified as negative prognostic markers. Conclusion Rheopheresis can be used as a potentially effective and safe salvage therapy for patients with cortico-refractory SISHL.http://link.springer.com/article/10.1186/s40463-017-0228-9RheopheresisSudden idiopathic hearing lossMicroWick
spellingShingle Milan Kostal
Jakub Drsata
Milan Bláha
Miriam Lánská
Viktor Chrobok
Rheopheresis in treatment of idiopathic sensorineural sudden hearing loss
Journal of Otolaryngology - Head and Neck Surgery
Rheopheresis
Sudden idiopathic hearing loss
MicroWick
title Rheopheresis in treatment of idiopathic sensorineural sudden hearing loss
title_full Rheopheresis in treatment of idiopathic sensorineural sudden hearing loss
title_fullStr Rheopheresis in treatment of idiopathic sensorineural sudden hearing loss
title_full_unstemmed Rheopheresis in treatment of idiopathic sensorineural sudden hearing loss
title_short Rheopheresis in treatment of idiopathic sensorineural sudden hearing loss
title_sort rheopheresis in treatment of idiopathic sensorineural sudden hearing loss
topic Rheopheresis
Sudden idiopathic hearing loss
MicroWick
url http://link.springer.com/article/10.1186/s40463-017-0228-9
work_keys_str_mv AT milankostal rheopheresisintreatmentofidiopathicsensorineuralsuddenhearingloss
AT jakubdrsata rheopheresisintreatmentofidiopathicsensorineuralsuddenhearingloss
AT milanblaha rheopheresisintreatmentofidiopathicsensorineuralsuddenhearingloss
AT miriamlanska rheopheresisintreatmentofidiopathicsensorineuralsuddenhearingloss
AT viktorchrobok rheopheresisintreatmentofidiopathicsensorineuralsuddenhearingloss